Article Information
History
- April 24, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Swaminathan P. Iyer1,*,
- Joe Ensor2,
- Kartik Anand3,
- Patrick Hwu4,
- Vivek Subbiah4,
- Christopher Flowers1 and
- Rudragouda Channappanavar5
- 1Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
- 2Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, Texas, USA
- 3Department of Oncology, Great Plains Health/Callahan Cancer Center, North Platte, Nebraska
- 4Department of Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
- 5Departments of Acute and Tertiary Care, and Microbiology, Immunology, & Biochemistry, Institute for the Study of Host-Pathogen Systems, The University of Tennessee Health Science Center
- ↵*Corresponding author:
Swaminathan P. Iyer, MD, Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, 1400, Unit 429, Holcombe Blvd, Houston, TX, Phone: +1 713-792-5242, Fax:713-745-7423, Email: spiyer{at}mdanderson.org
Posted April 24, 2020.
Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes
